A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients

Figure 10

Boxplots present the estimated IC50 value of chemotherapy drugs in two risk groups. (a) AMG 706, (b) gefitinib, (c) cisplatin, and (d) docetaxel in the TCGA. (e) AMG 706, (f) gefitinib, (g) cisplatin, and (h) docetaxel in the ICGC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)